Japanese Journal of Radiology

, Volume 35, Issue 12, pp 748–754 | Cite as

A novel utility of 99mTc-GSA SPECT/CT fusion imaging: detection of inadequate portal vein embolization

  • Tatsuaki Sumiyoshi
  • Yasuo Shima
  • Takehiro Okabayashi
  • Yasuhiro Hata
  • Yoshihiro Noda
  • Michihiko Kouno
  • Yuichi Saisaka
  • Kenta Sui
  • Sojiro Morita
  • Yuji Negoro
  • Taijiro Sueda
Original Article
  • 70 Downloads

Abstract

Purpose

Our aim was to determine the utility of Tc-99m-diethylenetriaminepentaacetic acid-galactosyl human serum albumin single-photon-emission computed tomography (99mTc-GSA SPECT/CT) fusion imaging for detecting incomplete portal vein embolization (PVE).

Materials and methods

Fifty-five candidates underwent PVE. Among them, five underwent second PVE. Detectability of first inadequate PVE using CT and 99mTc-GSA SPECT/CT fusion imaging was analyzed.

Results

Cases of inadequate PVE were detected in three patients using CT and in five using 99mTc-GSA SPECT/CT fusion imaging. Fusion imaging detected two cases of insufficient PVE in which portal branches were apparently well embolized on CT. Median value for volumetric rate in the embolized liver was 63.3% after the first PVE and 54.7% after the second (P < 0.01). Median functional rate value in embolized liver was 60.1% after the first PVE and 49.4% after the second (P < 0.01). Median value for change of volumetric and functional rates in embolized liver after the second PVE was 7.1 and 10.3%, respectively, and change of functional rate was greater than that of volumetric rate (P < 0.01).

Conclusions

99mTc-GSA SPECT/CT fusion imaging was useful for detecting inadequate PVE, and second PVE was effective for increasing volumetric and functional rates.

Keywords

99mTc-GSA SPECT/CT fusion imaging Portal vein embolization Extended hepatectomy 

Notes

Compliance with ethical standards

Funding

We received no financial support.

Conflict of interest

We have no conflict of interest to declare.

References

  1. 1.
    Makuuchi M, Takayasu K, Takuma T, Yamazaki S, Hasegawa H, Nishiura S, et al. Preoperative transcatheter embolization of the portal venous branch for patients receiving extended lobectomy due to the bile duct carcinoma (in Japanese). J Jpn Soc Clin Surg. 1984;45:14–20.Google Scholar
  2. 2.
    Makuuchi M, Thai BL, Takayasu K, Takayama T, Kosuge T, Gunvén P, et al. Preoperative portal embolization to increase safety major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery. 1990;107:521–7.PubMedGoogle Scholar
  3. 3.
    Kinoshita H, Sakai K, Hirohashi K, Igawa S, Yamasaki O, Kubo S. Preoperative portal vein embolization for hepatocellular carcinoma. World J Surg. 1986;10:803–8.CrossRefPubMedGoogle Scholar
  4. 4.
    Lee KC, Kinoshita H, Hirohashi K, Kubo S, Iwasa R. Extension of surgical indications for hepatocellular carcinoma by portal vein embolization. World J Surg. 1993;17:109–15.CrossRefPubMedGoogle Scholar
  5. 5.
    Shimamura T, Nakajima Y, Une Y, Namieno T, Ogasawara K, Yamashita K, et al. Efficacy and safety of preoperative percutaneous transhepatic portal embolization with absolute ethanol: a clinical study. Surgery. 1997;83:135–41.CrossRefGoogle Scholar
  6. 6.
    Kawasaki S, Makuuchi M, Kakazu T, Miyagawa S, Takayama T, Kosuge T, et al. Resection for multiple metastatic liver tumors after portal embolization. Surgery. 1994;115:674–7.PubMedGoogle Scholar
  7. 7.
    Baere T, Roche A, Elias D, Lasser P, Lagrange C, Bousson V. Preoperative portal vein embolization for extension of hepatectomy indications. Hepatology. 1996;24:1386–91.CrossRefPubMedGoogle Scholar
  8. 8.
    Nagino M, Nimura Y, Hayakawa N. Percutaneous transhepatic portal embolization using newly devised catheters. World J Surg. 1993;17:520–4.CrossRefPubMedGoogle Scholar
  9. 9.
    Nagino M, Nimura Y, Kamiya J, Kondo S, Uesaka K, Kin Y, et al. Right or left trisegment portal vein embolization before hepatic trisegmentectomy for hilar bile duct carcinoma. Surgery. 1995;117:677–81.CrossRefPubMedGoogle Scholar
  10. 10.
    Nagino M, Nimura Y, Kamiya J, Kondo S, Kanai M. Selective percutaneous transhepatic embolization of the portal vein in preparation for extensive liver resection: the ipsilateral approach. Radiology. 1996;200:559–63.CrossRefPubMedGoogle Scholar
  11. 11.
    Beppu T, Hayashi H, Okabe H, Masuda T, Mima K, Otao R, et al. Liver functional volumetry for portal vein embolization using a newly developed 99mTc-galactosyl humanserum albumin scintigraphy SPECT-computed tomography fusion system. J Gastroenterol. 2011;46:938–43.CrossRefPubMedGoogle Scholar
  12. 12.
    Akaki S, Okumura Y, Sasai N, Sato S, Tsunoda M, Kuroda M, et al. Hepatectomy simulation discrepancy between radionuclide receptor imaging and CT volumetry: influence of decreased unilateral portal venous flow. Ann NuclMed. 2003;17:23–9.CrossRefGoogle Scholar
  13. 13.
    Kwon AH, Matsui Y, Ha-Kawa SK, Kamiyama Y. Functional hepatic volume measured by technetium-99m-galactosylhuman serum albumin liver scintigraphy: comparison between hepatocyte volume and liver volume by computed tomography. Am J Gastroenterol. 2001;96:541–6.CrossRefPubMedGoogle Scholar
  14. 14.
    Satoh K, Yamamoto Y, Nishiyama Y, Wakabayashi H, Ohkawa M. 99mTc-GSA liver dynamic SPECT for the preoperative assessment of hepatectomy. Ann Nucl. 2003;17:61–6.CrossRefGoogle Scholar
  15. 15.
    de Graaf W, Bennink RJ, Veteläinen R, van Gulik TM. Nuclear imaging techniques for the assessment of hepatic function in liver surgery and transplantation. J Nucl Med. 2010;51:742–52.CrossRefPubMedGoogle Scholar
  16. 16.
    Sumiyoshi T, Shima Y, Okabayashi T, Noda Y, Hata Y, Murata Y, et al. Functional discrepancy between two liver lobes after hemilobe biliary drainage in patients with jaundice and bile duct cancer: an appraisal using (99m)Tc-GSA SPECT/CT fusion imaging. Radiology. 2014;273:444–51.CrossRefPubMedGoogle Scholar
  17. 17.
    Sumiyoshi T, Shima Y, Okabayashi T, Kozuki A, Hata Y, Noda Y, et al. Liver function assessment using 99mTc-GSA single-photon emission computed tomography (SPECT)/CT fusion imaging in hilar bile duct cancer: a retrospective study. Surgery. 2016;160:118–26.CrossRefPubMedGoogle Scholar
  18. 18.
    Nanashima A, Sumida Y, Abo T, Sakamoto I, Ogawa Y, Sawai T, et al. Usefulness of measuring hepatic functional volume using Technetium-99m galactosyl serum albumin scintigraphy in bile duct carcinoma: report of two cases. J Hepatobiliary Pancreat Surg. 2009;16:386–93.CrossRefPubMedGoogle Scholar
  19. 19.
    Cescon M, Vetrone G, Grazi GL, Ramacciato G, Ercolani G, Ravaioli M, et al. Trends in perioperative outcome after hepatic resection: analysis of 1500 consecutive unselected cases over 20 years. Ann Surg. 2009;249:995–1002.CrossRefPubMedGoogle Scholar
  20. 20.
    Nagino M, Kamiya J, Nishio H, Ebata T, Arai T, Nimura Y. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg. 2006;243:364–72.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Akaki S, Mitsumori A, Kanazawa S, Takeda Y, Joja I, Hiraki Y, et al. Reduced radioactivity in the periphery of the liver in a patient with idiopathic portal hypertension. Clin Nucl Med. 1997;22:369–71.CrossRefPubMedGoogle Scholar

Copyright information

© Japan Radiological Society 2017

Authors and Affiliations

  • Tatsuaki Sumiyoshi
    • 1
  • Yasuo Shima
    • 1
  • Takehiro Okabayashi
    • 1
  • Yasuhiro Hata
    • 2
  • Yoshihiro Noda
    • 2
  • Michihiko Kouno
    • 2
  • Yuichi Saisaka
    • 1
  • Kenta Sui
    • 1
  • Sojiro Morita
    • 2
  • Yuji Negoro
    • 3
  • Taijiro Sueda
    • 4
  1. 1.Department of Gastroenterological SurgeryKochi Health Sciences CenterKochiJapan
  2. 2.Department of RadiologyKochi Health Sciences CenterKochiJapan
  3. 3.Department of Medical OncologyKochi Health Sciences CenterKochiJapan
  4. 4.Department of Surgery, Applied Life Sciences Institute of Biomedical and Health SciencesHiroshima UniversityHiroshimaJapan

Personalised recommendations